Research has shown that PEDF is among the most potent physiological and pathological anti-angiogenic factors, with both direct and indirect oppressive effects on tumour proliferation, though this remains to be tested clinically in the context of therapy. This evidence concerns the gene SERPINF1 and neoplasm.